comparemela.com

Latest Breaking News On - State drug administration - Page 1 : comparemela.com

Co-creating a New Future: Infinitus Global Annual Conference 2024 Convenes in Guangdong

Akeso Announced that Ivonescimab Granted Priority Review of NDA by China NMPA

Akeso Announced that Ivonescimab Granted Priority Review of NDA by China NMPA
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

Akeso Announced NDA Acceptance of IL-12/lL-23 Monoclonal Antibody Ebdarokimab for Moderate-to-severe Plaque Psoriasis by China NMPA

HONG KONG, Aug. 24, 2023 /PRNewswire/ Akeso Inc. , a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class and best-in-class innovative medicines.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.